ASCO Annual Meeting 2023: Radiation Therapy May Not Be Needed After Chemoimmunotherapy for Primary Mediastinal B-cell Lymphoma
The ASCO Annual Meeting is being held June 2 to 6. A study presented today shows that removing radiation therapy from the treatment plan for an aggressive form of lymphoma does not impact the risk of recurrence or overall survival.